Support Consistent Research With Defined Umbilical Cord-Derived MSCs

Reducing variability early is critical for advancing umbilical cord-derived MSC therapies from research to scale-up. By combining standardized UC-MSC sourcing with xeno- and serum-free expansion media and DMSO-free cryopreservation, researchers can establish more consistent workflows that support reproducible outcomes throughout development. Umbilical cord-derived MSCs offer advantages including strong proliferation potential, lower donor-to-donor variability, broad differentiation capabilities, and scalable manufacturing performance. A streamlined source-to-scale approach integrates defined starting material, controlled culture conditions, and optimized preservation strategies to help improve process consistency from discovery through translational research.

For teams looking to strengthen MSC manufacturing workflows, this brochure highlights practical solutions for establishing standardized, research-ready processes that support long-term development goals.